ANGO
AngioDynamics Inc
NASDAQ: ANGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$14.63
+2.02% today
Updated 2026-07-29
Market cap
$571.21M
P/E ratio
—
P/S ratio
1.78x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$8 – $15
Volume
0.4M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C5.5
Quality
C+2.0
Profitability
F7.0
Valuation
B+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$20.00
+36.71%
12-Month target
—
—
Intrinsic (DCF)
$18.54
Margin of safety
+38.67%
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $17.04M — positive
+ 38.67% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -11.50%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $338.75M | $303.91M | $292.50M | $320.17M | $320.17M |
| Net income | $-52.44M | $-184.35M | $-33.99M | $-36.74M | $-11.40M |
| EPS | — | — | — | — | $-0.86 |
| Free cash flow | $-4.27M | $-33.93M | $-14.59M | $508000.00 | $17.04M |
| Profit margin | -15.48% | -60.66% | -11.62% | -11.48% | -11.50% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-07-22 | TROWBRIDGE, STEPHEN A | Sale | 57,381 | — |
| 2026-07-22 | TROWBRIDGE, STEPHEN A | Buy | 16,296 | — |
| 2026-07-22 | TROWBRIDGE, STEPHEN A | Sale | 8,319 | $13.82 |
Peer comparison
Smart narrative
AngioDynamics Inc trades at $14.63. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $320.17M. with profit margins at -11.50%. Our DCF model estimates intrinsic value at $18.54.
Frequently asked questions
What is AngioDynamics Inc's stock price?
AngioDynamics Inc (ANGO) trades at $14.63, on a P/S of 1.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is AngioDynamics Inc overvalued?
AngioDynamics Inc carries a Smart Value Score of 40/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $18.54 versus the $14.63 price, a 38.7% margin of safety on a cash flow basis.
What is the price target of AngioDynamics Inc (ANGO)?
The 12-month analyst consensus target is $20.00, about 36.7% above the current $14.63. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of AngioDynamics Inc (ANGO)?
Our DCF model estimates intrinsic value at $18.54, a +38.7% margin of safety versus today's $14.63. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is AngioDynamics Inc's revenue?
AngioDynamics Inc's trailing twelve-month revenue is $320.17M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.78x
ROE-21.51%
Beta0.34
50D MA$12.33
200D MA$11.67
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.4M
Performance
1 week-3.94%
1 month+1.94%
3 months+24.41%
YTD+6.39%
1 year—
3 years—
5 years—